According to Odaily Planet Daily, Two Seas Capital, Core Scientific's largest active shareholder, has issued an open letter stating that it will vote against the proposed $9 billion sale of Core Scientific to CoreWeave at a shareholder meeting later this year. Two Seas Capital called the valuation "manifestly inadequate" and urged other shareholders to join in opposing the deal. Previous reports indicated that CoreWeave had announced on July 7th its acquisition of Core Scientific in an all-stock transaction valued at $9 billion, representing a 66% premium to Core Scientific's share price when negotiations resumed on June 25th. (prnewswire)